Clinical Trials
33 trialsNCT04660929 2024-12-18
CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors
Carisma Therapeutics Inc
Phase 1 Unknown
NCT05872867 2024-03-12
MK-3475-E90
Wellmarker Bio
Phase 1 Unknown
NCT06011291 2023-10-27
A Study of SYH2051 Monotherapy in Advanced Solid Tumors or in Combination With Radiotherapy in Locally Advanced Head and Neck Cancer
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Phase 1 Unknown
NCT05994638 2023-10-13
Polyphenol Rich Aerosol as a Support for Cancer Patients in Minimizing Side Effects After a Radiation Therapy
AronPharma Sp. z o. o.
Phase NA Unknown
NCT05658016 2023-08-14
Phase 2a Study to Evaluate Suppression of Radiotherapy-induced Mucositis by TK112690
Tosk, Inc.
Phase 2 Unknown
NCT05708950 2023-07-13
A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)
Kineta Inc.
Phase 1/2 Unknown
NCT05549414 2023-07-10
PPTS
P-Cure
Phase NA Unknown
NCT05886075 2023-06-02
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors
Shanghai Yunying Medical Technology
Phase EARLY_PHASE1 Unknown
NCT05830240 2023-04-26
A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Relapsed/Refractory Head and Neck Cancer
Shanghai Yunying Medical Technology
Phase EARLY_PHASE1 Unknown
NCT05801770 2023-04-06
Discovering Factors in Head and Neck Cancer Patients' Clinical Study Experiences
Power Life Sciences Inc.
Unknown
NCT01946867 2022-12-29
NBTXR3 and Radiation Therapy in Treating Patients With Locally Advanced SCC of the Oral Cavity or Oropharynx
Nanobiotix
Phase NA Unknown
NCT04801095 2022-09-16
A Phase I Study of WM-S1-030 in Patients With Advanced Solid Tumors
Wellmarker Bio
Phase 1 Unknown
NCT03634982 2022-09-01
Dose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid Tumors
Revolution Medicines, Inc.
Phase 1 Unknown
NCT04460456 2022-06-30
A Study of SBT6050 Alone and in Combination With PD-1 Inhibitors in Subjects With Advanced HER2 Expressing Solid Tumors
Silverback Therapeutics
Phase 1 Unknown
NCT05122221 2022-06-28
CRTE7A2-01 TCR-T Cell for HPV-16 Positive Advanced Cervical, Anal, or Head and Neck Cancers
Corregene Biotechnology Co., Ltd
Phase 1 Unknown
NCT04963972 2022-05-10
Digital and Behavioral Tele-Health Tapering Program for Lowering Dependence on Opioids in Patients Undergoing Surgery
Lucid Lane, Inc
Phase NA Unknown
NCT04697446 2021-08-10
External Control, Observational, Retrospective Study Comparing Pralsetinib to Best Available Therapy in Patients With RET-Fusion Positive NSCLC
Blueprint Medicines Corporation
Unknown
NCT03552406 2021-05-06
Study of ISU104, Targeting ERBB3 in Patients With Advanced Solid Tumors
ISU Abxis Co., Ltd.
Phase 1 Unknown
NCT03896958 2020-12-04
PIONEER
SpeciCare
Unknown
NCT03874741 2020-05-27
SCT200 Plus Platinum-based Chemotherapy in Head and Neck Squamous Cell Carcinoma
Sinocelltech Ltd.
Phase 2 Unknown
NCT04073680 2020-05-21
A Phase 1b/2 Study of Serabelisib in Combination With Canagliflozin in Patients With Advanced Solid Tumors
Petra Pharma
Phase 1/2 Unknown
NCT03713372 2020-03-23
Safety and Efficacy of SCT200 in Head and Neck Squamous Cell Carcinoma
Sinocelltech Ltd.
Phase 2 Unknown
NCT04066335 2019-12-18
Study to Evaluate the Safety of Nanoxel M Inj.
Samyang Biopharmaceuticals Corporation
Unknown
NCT02433626 2019-02-01
COTI2-101
Critical Outcome Technologies Inc.
Phase 1 Unknown
NCT02980653 2017-01-18
Megestrol Acetate Against Cancer-related Critical Body Weight Loss in Patients With H&N Cancer Who Receiving CCRT
TTY Biopharm
Phase 2 Unknown
NCT02070432 2016-03-03
Photodynamic Therapy With LUZ11 in Advanced Head and Neck Cancer
Luzitin SA
Phase 1/2 Unknown
NCT02630264 2015-12-15
E10A for the Treatment of Squamous Cell Carcinoma of the Head and Neck
Guangzhou Double Bioproducts Co., Ltd
Phase 3 Unknown
NCT02429037 2015-04-29
P53 Gene Combined With Radio- and Chemo-therapy in Treatment of Unresectable Locally Advanced Head and Neck Cancer
Shenzhen SiBiono GeneTech Co.,Ltd
Phase 2 Unknown
NCT02283489 2014-11-05
Recombinant Human Endostatin Adenovirus Combined With Chemotherapy for Advanced Head and Neck Malignant Tumors
Chengdu Shi Endor Biological Engineering Technology Co., Ltd
Phase 2 Unknown
NCT01247246 2014-05-26
Study to Evaluate the Efficacy and Safety of Three Different Doses of SCV 07 in Attenuating Oral Mucositis in Subjects With Head and Neck Cancer
SciClone Pharmaceuticals
Phase 2 Unknown
NCT01260480 2010-12-17
An Efficacy and Safety Study to Assess [18F]-ML-10 in Detecting Response of Tumors to Chemotherapy and Radiation
Aposense Ltd.
Phase 2 Unknown
NCT00710697 2009-09-24
Cardiac Safety Assessment Study of Picoplatin in Solid Tumors
Poniard Pharmaceuticals
Phase 1 Unknown
NCT00090727 2006-11-02
Chemotherapy for Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma
Novacea
Phase 1 Unknown